Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-11-30 8:19 pm Purchase | 13D | Streamline Health Solutions, Inc. STRM | Tamarack Advisers LP | 5,128,308 10.7% | 92,245![]() (+1.83%) | View |
2021-03-22 7:51 pm Purchase | 13D | Streamline Health Solutions, Inc. STRM | Tamarack Advisers LP | 5,036,063 12.1% | 693,929![]() (+15.98%) | View |
2021-02-12 6:02 pm Sale | 13G | IVERIC bio, Inc. ISEE | Tamarack Advisers LP | 850,000 0.1% | -1,800,000![]() (-67.92%) | View |
2020-02-14 1:03 pm Sale | 13G | OBALON THERAPEUTICS INC OBLN | Tamarack Advisers LP | 0 0% | -2,100,000![]() (Position Closed) | View |
2020-02-13 9:39 pm Purchase | 13G | Correvio Pharma Corp. CORV | Tamarack Advisers LP | 2,500,000 4.9% | 375,000![]() (+17.65%) | View |
2020-02-13 9:37 pm Purchase | 13G | IVERIC bio, Inc. ISEE | Tamarack Advisers LP | 2,650,000 5.5% | 2,650,000![]() (New Position) | View |
2019-12-13 5:07 pm Unchanged | 13D | Streamline Health Solutions, Inc. STRM | Tamarack Advisers LP | 4,342,134 14.2% | 0 (Unchanged) | View |
2019-11-08 4:43 pm Purchase | 13G | Streamline Health Solutions, Inc. STRM | Tamarack Advisers LP | 4,342,134 14.2% | 2,392,134![]() (+122.67%) | View |
2019-02-15 08:32 am Purchase | 13G | OBALON THERAPEUTICS INC OBLN | Tamarack Advisers LP | 2,100,000 9% | 2,100,000![]() (New Position) | View |
2019-02-14 6:52 pm Purchase | 13G | Streamline Health Solutions, Inc. STRM | Tamarack Advisers LP | 1,950,000 9.7% | 900,000![]() (+85.71%) | View |
2019-02-14 6:50 pm Sale | 13G | Cardiome Pharma Corp. CRME | Tamarack Advisers LP | 0 0% | -1,875,000![]() (Position Closed) | View |
2019-02-14 6:40 pm Purchase | 13G | Correvio Pharma Corp. CORV | Tamarack Advisers LP | 2,125,000 6.1% | 2,125,000![]() (New Position) | View |